Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.
NEW YORK (TheStreet) -- Every night, Jim Cramer sits down with CEOs and executives on his "Mad Money" show to discuss their business, the economy, politics and more. Today we look back at his recent interviews with Daniel Starks of St. Jude Medical (STJ) and Stephen Holmes of Wyndham Worldwide (WYN).
These are excerpts from Cramer's 'Mad Money' Recap, originally published on Feb. 7, 2014.
Executive Decision: Daniel Starks
For his "Executive Decision" segment, Cramer sat down with Daniel Starks, chairman and CEO of St. Jude Medical, a stock that was up 72% last year and hasn't given up any of its gains so far this year. St. Jude just posted a penny-a-share earnings beat on in-line revenue and guidance.
Starks showed off his company's new, revolutionary pacemaker, currently in clinical testing. The device, which is a fraction of the size of current pacemakers, can be implanted through a non-invasive procedure in as little as eight minutes, and the unit will last for up to 19 years. Starks said that in his opinion, once the device is available there will simply be no reason to choose anything else.
St. Jude currently controls nearly a quarter of the CRM, or cardiac rhythm management, market and its new device will only solidify that dominant position. St. Jude is also working on treatments for hypertension, particularly for patients who don't respond to other treatments.